Skip to main content
SpringerLink
Log in

Immunosuppressive Therapie

  • Conference paper
Ergebnisse der Inneren Medizin und Kinderheilkunde

  • 25 Accesses

Zusammenfassung

Der Begriff „Immunosuppression“ erscheint zunächst paradox. Warum sollte man die für die mikrobielle Abwehr unerläßliche Immunoantwort dämpfen wollen. Dazu werden Medikamente gebraucht, welche in der Regel sehr relevante direkte oder indirekte Nebenwirkungen verursachen. Es ist deshalb begreiflich, daß die Entwicklung einer immunosuppressiven Therapie auf großen Widerstand gestoßen ist.

Division d’Hématologie, Hôpital universitaire, Genève.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. AISENBERG, A. C.: STUDIES on cyclophosphamide-induced tolerance to sheep erythrocytes. J. exp. Med. 125, 833 (1967).

    Article  PubMed  CAS  Google Scholar 

  2. ALEPA,F.L., ZVAIFLER,N. J., SLIWINSKI,A. J.: Immunologic effects of cyclophosphamide treatment in rheumatoid arthritis. Arthr. and Rheum. 13, 754 (1970).

    Article  Google Scholar 

  3. AMBROSE, L.T.: Regulation of the secondary antibody response in vitro. Enhancement by actinomycin D and inhibition by a macromolecular product of stimulated lymph node cultures. J. exp. Med. 130, 1003 (1969).

    Article  PubMed  CAS  Google Scholar 

  4. BENACERRAF, B., GELL, P. H. G.: Studies on hypersensitivity. I. Delayed and Arthus- type skin reactivity to protein conjugates in Guinea pigs. Immunology 2, 53 (1959).

    PubMed  CAS  Google Scholar 

  5. BERENBAUM, M. C.: Is azathioprina a better immunosuppressant than 6-mercapto- purine ? Clin. exp. Immunol. 8, 1 (1971).

    CAS  Google Scholar 

  6. BROWN, N.: The effect of delayed administration of folinic acid on immunologic inhibition by methotrexate. Immunology 8, 251 (1965).

    PubMed  Google Scholar 

  7. Immunosuppression of L-asparaginase. Nature (Lond.) 225, 550 (1970).

    Article  Google Scholar 

  8. BERTINO, J.R., HILLCOAT,B.C., JOHNS,D.G.: Folate antagonists: some biochemical considerations. Fed. Proc. 26, 893 (1967).

    PubMed  CAS  Google Scholar 

  9. BOESEN,E., DAVIS,W.: In: ARNOLD,E. (Ed.): Cytotoxic drugs in the treatment of cancer, S. 208ff. London, 1969.

    Google Scholar 

  10. BONTOUX,D., KAHAN,A., BROUILHET,H., AMOR,B., DELBARRE, F., JOUANNEAU,M., GNIAZOOWSKA, E.: Effect and mode of action of chlorambucil in rheumatoid arthritis. Rev. Europ. Etud. Clin. Biol. 16, 166 (1971).

    Google Scholar 

  11. BOREL, Z., FAUCONNET,M., MIESCHER, P. A.: The effect of 6-mercaptopurine and methotrexate on passive delyed hypersensitivity reactions. Int. Arch. Allergy 38, 583 (1968).

    Google Scholar 

  12. BORNSTEIN, M. B.: Autoimmune phenomena of the central nervous system. In: MULLER- EBERHARD,H., MIESCHER,P.A. (Eds.): Textbook of immunopathology, p. 507ff. New York: Grune & Stratton 1969.

    Google Scholar 

  13. BOURONCLE, G. A., DOAN, C.A.: J. Amer. med. Ass. 207, 2049 (1969).

    Article  CAS  Google Scholar 

  14. BRANDISS,M.W., SMITH, J. W., FRIEDMAN, R. M.: Suppression of experimental allergic encephalomyelitis by antimetabolites. Ann. N. Y. Acad. Sci. 122, 356 (1965).

    Google Scholar 

  15. BRODY,N.I., WALKER, J.G., SISKIND,G.W.: Studies on the control of antibody synthesis. J. exp. Med. 126, 81 (1967).

    Article  Google Scholar 

  16. CEROTTINI,J.C., MCCONAHEY,P.J., DIXON,F.J.: The immunosuppressive effect of passively administered antibody IgG fragments. J. Immunol. 102, 1008 (1969).

    Google Scholar 

  17. DAVID, J. R.: Suppression of delayed hypersensitivity in vitro by inhibition of protein synthesis. J. exp. Med. 122, 1125 (1965).

    Article  PubMed  CAS  Google Scholar 

  18. DELWAIDE,I., SALMON, J., VAN CAUWENBERGE, H.: Premiers essais de traitement de la myasthénie par azethioprine. Acta neurol. belg. 67, 701 (1967).

    Google Scholar 

  19. DEWAYNE,R., LOEHR,E.V.: Methotrexate and cytosine-arabinoside modulation of thymidilate synthetase activity in CCRF-CEM cells. Cancer Res. 31, 457 (1971).

    Google Scholar 

  20. DIXON, F. J., JACOT-GUILLERMOD,H., MCCONAHAY, P. J.: The effect of passively administered antibody on antibody synthesis. J. exp. Med. 125, 1119 (1967).

    CAS  Google Scholar 

  21. DRUMMOND, K. N.: Treatment with cyclophosphamide of resistent and relapsing nephrosis in childhood. Proc. 4 th International Congress Nephrology, Stockholm, 1969, 72. Basel: Karger 1970.

    Google Scholar 

  22. DUMONT,A.E.: In: RAPPAPORT, F. T., DAUSSET,J. (Eds.): Human transplantation, p. 482. New York: Grune & Stratton 1968.

    Google Scholar 

  23. DUKOR, P., DIETRICH, F.M.: Characteristic features of immunosuppression by steroids and cytotoxic drugs. Int. Arch. Allergy 34, 32 (1968).

    Article  PubMed  CAS  Google Scholar 

  24. ELION,G.B., BURGI,E., HITCHINGS, G. H.: Studies on condensed pyrimidine systems. IX. The synthesis of some 6-substituted purines. J. Amer. chem. Soc. 74, 411 (1952).

    Article  Google Scholar 

  25. ELION,G.B.: Biochemistry and pharmacology of purine analogues. Fed. Proc. 26, 898 (1967).

    Google Scholar 

  26. HITCHINGS, G. H.: Metabolic basis for the actions of analogs of purines and pyri- midines. Advanc. Chemotherapy 2, 91 (1965).

    Google Scholar 

  27. ELLIOTT, E.U., SINCLAIR, N.R.: Effect of cortisone acetate on 19 S and 7 S hemolysin antibody. A time course study. Immunology 15, 643 (1968).

    PubMed  CAS  Google Scholar 

  28. FAGRAEUS,A.: Role of ACTH and Cortisone in resistance and immunity. Acta path, microbiol. scand., Suppl. 93, 20 (1952).

    Google Scholar 

  29. FISHMAN,M., ADLER,F.L.: Antibody formation in vitro: In: Grabar,P., Miescher, P.A. (Eds.): Proc. Illrd International Symposium on Immunopathology. Basel: Schwabe & Co. 1963.

    Google Scholar 

  30. FLAD,H.D., MIESCHER,P.A.: The effect of methylhydrazine on experimental autoimmune thyroiditis. Int. Arch. Allergy 30, 507 (1966).

    Article  Google Scholar 

  31. FOSDICK,W.M., PARSONS, J. L., HILL,D.F.: Long-term cyclophosphamide therapy in rheumatoid arthritis. Arthr. and Rheum. 11, 151 (1968).

    Article  Google Scholar 

  32. FRIEDRICH, U., ZEUTHEN,E.: CHROMOSOME abnormalities and treatment with azathio- prine after kidney transplantation. Hum. Genet. 8, 289 (1970).

    Article  CAS  Google Scholar 

  33. GABRIELSEN, A. E., GOOD, R. A.: Chemical suppression of adaptive immunity. Advanc. Immunology 6, 91 (1967).

    Article  CAS  Google Scholar 

  34. GEREBTZOFF,A., LAMBERT,P.H., MIESCHER,P.A.: Immunosuppressive agents. An. Rev. Pharmacol. 12, 287 (1972).

    Article  Google Scholar 

  35. GILES, C.L., KAUFMAN, H. E., WONG, V. G.: The use of antimetabolites in ophthalmology. Amer. J. Sci. 251, 727 (1966).

    Google Scholar 

  36. GERSHON,R.K., CARTER, R.L.: Facilitation of metastatic growth by antilymphocyte serum. Nature (Lond.) 226, 368–370 (1970).

    Article  Google Scholar 

  37. GOOD,R.A.: Experimental and clinical experience with chemical suppression of immunity. In: Miescher,P.A., Grabar,P., (Eds.): Proc. Vth Internat. Symposium on Immunopathology, p. 366ff. Basel: Schwabe & Co. 1968.

    Google Scholar 

  38. GREAVES,M.W., BURTON, J. L., MARKS, J., DAWBER, R. P. R.: Azathioprine in treatment of bullous pemphigoid. Brit. med. J. 19711, 144.

    Google Scholar 

  39. GREEN, D.: Suppression of an antibody to Factor VIII by a combination of factor VIII and cyclophosphamide. Blood 37, 381 (1971).

    PubMed  CAS  Google Scholar 

  40. GRIFFITH, A. H.: Personal communication.

    Google Scholar 

  41. HAINES, R. F., JOHNSON, A. G., PETERING, H.G.: Variable influences of antitumor drugs and progestational agents on immunological response in rodents. Fed. Proc. 26, 934 (1967).

    PubMed  CAS  Google Scholar 

  42. HARRIS, G.: Antibody production in vitro. II. Effects of actinomycin D and puromycin on the secondary response to sheep erythrocytes. J. exp. Med. 127, 675 (1968).

    Article  PubMed  CAS  Google Scholar 

  43. HERDMAN,R.C., MICHAEL,A.F., GOOD,R.A.: Proc. IVth Internat. Congr. Nephrol., Stockholm, 1969, 3, 62. Basel: Karger 1970.

    Google Scholar 

  44. JONES,R.A.: Immunosuppressive therapy in Crohn’s disease. Proc. roy. Soc. Med. 64, 71 (1971).

    Google Scholar 

  45. KOMMERELL,B., SEELIGER, M.: Die Behandlung der chronischen Hepatitis mit im- munosuppressiven Substanzen. Dtsch. med. Wschr. 95, 2521 (1970).

    Google Scholar 

  46. LAMBERT, P. H.: Glomerulonephritis in NZB/W mice. Proc. IV th Internat. Congr. Nephrol., Stockholm, 1969. Basel: Karger 1970.

    Google Scholar 

  47. LANGE, K.: Immunosuppressive treatment of the nephrotic syndrome and glomerulonephritis. Proc. IVth Internat. Congr. Nephrol., Stockholm, 1969. Basel: Karger 3, 102 (1970).

    Google Scholar 

  48. LITTLE,P.A., OLSESON,J. J., ROESCH,P.K.: The effect of pteroylglutamic acid on some immune responses of chicks. J. Immunol. 65, 491 (1950).

    Google Scholar 

  49. MACKEY,R., WOOD, I. J.: The course and treatment of lupoid hepatitis. Gastroenterology 45, 4 (1963).

    Google Scholar 

  50. MAJ, E.D.E., NEWCOMER, K. L., OVERHOLT, E. L.: Goodpasture’s syndrome. Response to 6-mercaptopurine and prednisone. J. Amer. med. Ass. 213, 1849 (1970).

    Article  Google Scholar 

  51. MAKINODAN,T., SANTOS,G.W., QUINN,R.P.: Immunosuppressive drugs. Pharmacol. Rev. 22, 189 (1970).

    Google Scholar 

  52. MALAVIYA,A. N., MANY,A., SCHWARTY,R.S.: Treatment of dermatomyositis with methotrexate. Lancet 1968 II, 485.

    Article  PubMed  CAS  Google Scholar 

  53. MARMONT,A.: Personal communication.

    Google Scholar 

  54. MASON,M., CURREY,H.L. F., BARNES,C.G., DUNNE, J. F., HAZLEMAN,B. L., STRICKLAND, I.D.: Azathioprine in rheumatoid arthritis. Brit. Med. J. 19691, 420.

    Google Scholar 

  55. Medical Research Council Working Party on controlled trial of azathioprine and prednisone in chronic renal disease. Brit. med. J. 1971II, 239.

    Google Scholar 

  56. Meyer Zum Büschenfelde, K.H., Perings,E., Creutzfeldt, W.: Immunosuppressive Therapie chronisch entzündlicher Lebererkrankungen. Ther. Umsch. 28, 586 (1971).

    PubMed  Google Scholar 

  57. MIESCHER,P.A.: Autoimmune hemolytic anemia. In: Miescher,P.A., Müller- Eberhard, H. (Eds.): Textbook of immunopathology, p. 458. New York: Grüne & Stratton 1969.

    Google Scholar 

  58. LAMBERT, P. H.: Die immunosuppressive Therapie des systematischen Lupus erythematodes. Ther. Umsch. 28, 579 (1971).

    PubMed  Google Scholar 

  59. PARONETTO,F.: Systemic lupus erythematosus. In: MIESCHER,P.A., Müller-EBERHARD, H. (Eds.): Textbook of Immunopathology, p. 675. New York: Grüne & Stratton 1969.

    Google Scholar 

  60. RIETHMüLLER, D.: Immunosuppressive therapy of systemic lupus erythematosus Semin. Hematology 2, 1 (1965).

    Google Scholar 

  61. Die immunosuppressive Therapie des systemischen Lupus erythematodes. In: Riekenjd., Schumacher,K. (Hrsg.): Medikamentöse Immunosuppression, p. 69. Stuttgart: Georg Thieme 1971.

    Google Scholar 

  62. Bakteriell-allergische Vasculitiden als Ursache von Organerkrankungen. Schweiz, med. Wschr. 87, 1339 (1957).

    Google Scholar 

  63. MITCHISONJN.A.: Cell cooperation in the immune response: The hypothesis of an antigen presentation mechanism. In: Miescher,P.A. (Ed.): Proc. VIth Internat. Immunopathology Symposium, p. 52. Basel: Schwabe & Co. 1971.

    Google Scholar 

  64. NORTH,R.J.: Suppression of cell mediated immunity to infection by an antimitotic drug. Further evidence that migrant macrophages express immunity. J. exp. Med. 132, 535 (1970).

    Article  Google Scholar 

  65. NOTKINS,A.L., MERGENHAVEN,S.E., HOWARD,R.S.: Effect of virus infections on the function of the immune system. Ann. Rev. Microbiol. 24, 525 (1970).

    Article  Google Scholar 

  66. Effect of virus infections on immune function. In: Miescher,P.A. (Ed.): VIth Internat. Symposium on Immunopathology, p. 413. Basel: Schwabe & Co. 1971.

    Google Scholar 

  67. O’brien,W.M., VAN SCOTT,E. J., BLACK,R.L., EISEN,A.Z., BUNIM, J.J.: Clinical trial of amathopterin (methotrexate) in psoriatic and rheumatoid arthritis (preliminary report). Arthr. and Rheum. 5, 312 (1962).

    Google Scholar 

  68. OHNO,R., HARRIS, J.E., HERSH,E.M.: L-Asparaginase: suppression of the immune response of mice to sheep red blood cells. Clin. exp. Immunol. 7, 221 (1970).

    Google Scholar 

  69. HERSH, E.M.: Immunosuppressive effects of L-Asparaginase. Cancer Res. 30, 1605 (1970).

    Google Scholar 

  70. OSSERMAN,K.E.: Immunopathology of myasthenia gravis. In: MIESCHER,P.A., MÜLLER-EBERHARD,H. (Eds.): Textbook of immunopathology, p. 607. New York: Grune & Stratton 1959.

    Google Scholar 

  71. PAGE,A.R., CONDIE,R.M., GOOD,R.A.: Effect of 6-MP on inflammation. Amer. J. Path. 40, 519 (1962).

    Google Scholar 

  72. PARKER,C.W., VAVRA, J.D.: Immunosuppression. In: Progr. Hemat. 6, 1 (1969).

    Google Scholar 

  73. PHADKE,A.G., MACKINNON,K.J., DOSSETOR,J.B.: Male fertility in uremia: restoration by renal allografts. Canad. med. Ass. J. 102, 607 (1970).

    Google Scholar 

  74. PIRQUET,Von: Der Einfluß von Masern auf die Tuberkulin-Allergie. Dtsch. med. Wschr. 30, 1297 (1906).

    Google Scholar 

  75. PISCIOTTA,A.V., DEPREY,C.: Inhibition of mitosis by chloramphenicol in Phytohämagglutinin stimulated lymphocytes. Blood 30, 457 (1967).

    Google Scholar 

  76. POLLACK, W., GORMAN, J.G., FRED A,U. J.: Prevention of Rh hemolytic disease. Progr. Hemat. 6, 121 (1969).

    CAS  Google Scholar 

  77. PORTER,D.D., LARSEN,A.E.: The immunopathology of the aleutian disease of mink. In: Miescher, P. A. (Ed.): Proc. VI th Internat. Symp. on Immunopathology, p. 404. Basel: Schwabe & Co. 1971.

    Google Scholar 

  78. PRAGER, M.D., JASIN,H.E., DERR,I., ROTHBERG,L.: Mechanism of Immunosuppression by L-Asparaginase. Fed. Proc. 30, 590 (1971).

    Google Scholar 

  79. ROWLEY,D. A., FITCH, F.W., AXELROD,M.A., PIERCE, C.W.: The immune response suppressed by specific antibody. Immunology 16, 549 (1969).

    Google Scholar 

  80. SALAMAN,M.H.: Immunosuppressive effects in infection. Proc. roy. Soc. Med. 83, 11 (1970).

    Google Scholar 

  81. SALMON, J., LAMBERT, P. H.: Traitement des maladies auto-immunes par les anti- mitotiques. Arch. belg. Derm. 24, 297 (1968).

    CAS  Google Scholar 

  82. SARLES,H.E., THOMAS,F.D., REMMERS,A.R., CANALES,C.O., SMITH,G.H., BEAT-HARD, G. A.: Immunosuppressive drugs, a review. Tex. Rep. Biol. Med. 27, 327 (1969).

    Google Scholar 

  83. SCHERF,H.R., KORSTEN,C., Krüger, C: Tierexperimentelle Untersuchungen über immunosuppressive Wirkungen von Cytostatica. Langenbecks Arch. Chir. 325, 1028–1033 (1969).

    Google Scholar 

  84. SCHUBERT, J. C. F., SCHUBERT, H., HOLTZ, G., MARTIN, H.: Immunosuppressive Langzeittherapie des lupus erythematodes visceraüs. Dtsch. med. Wschr. 95, 1768 (1970).

    CAS  Google Scholar 

  85. SCHUBOTHE,H.: The cold hemagglutinin disease. Sem. Hemat. 3, 27 (1966).

    Google Scholar 

  86. SCHWARTZ, R., DAMESHEK,W.: Drug induced immunologic tolerance. Nature (Lond.) 183, 1682 (1959).

    Article  CAS  Google Scholar 

  87. STACK, J., DAMESHEK,W.: Effect of 6-MP on antibody production. Proc. Soc. exp. Biol. (N. Y.) 99, 164 (1958).

    Google Scholar 

  88. SCHWARTZ,R.S.: Immunosuppressive drug therapy. In: Rappaport,E.T., Dausset,J. (Eds.): Human transplantation, p. 440. New York: Grune & Stratton 1968.

    Google Scholar 

  89. Immunosuppression by L-Asparaginase. Nature 224, 275 (1969).

    Article  Google Scholar 

  90. SCHWARTZ, R.S., DAMESHEK,W.: The treatment of autoimmune hemolytic anemia with 6-Mercaptopurine and thioguanine. Blood 19, 483 (1962).

    PubMed  CAS  Google Scholar 

  91. Immunosuppressive therapy, immunologic correlation and clinical results. In: Miescher,P.A., Graber,D. (Eds.): Proc. Vth Internat. Symp. Immunopathology. p. 3CQ. Basel: Schwabe & Co. 1968.

    Google Scholar 

  92. Are immunosuppressive anticancer drugs self defecting ? Cancer Res. 28, 1452–1454 (1968).

    Google Scholar 

  93. SHERLOCK,SH.: Diseases of the liver and biliary system. 4th edition. Blackwell Sei. Publ., Oxford-Edinburgh: 1968.

    Google Scholar 

  94. SHULMAN,L.E.: Dermatomyositis. In: MIESCHER,D. A., Müller-Eberhard,H. (Eds.) Textbook of immunopathology. New York: Grune & Stratton. 1969. p. 713.

    Google Scholar 

  95. SOOTHILL, J. F., BARRATT,T.M., MCLAINE,P.N.: Controlled studies of the treatment of steroid resistant and steroid sensitive relapsing nephrotic syndrome. In: Proc. IVth Internat. Congr. Nephrology. Stockholm, 1969, 3, 88. Basel: Karger 1970.

    Google Scholar 

  96. SPIEGELBERG, H.L., MIESCHER, P.A.: The effect of 6 MP and methotrexate on experimental immune thyroiditis in guinea pigs. J. exp. Med. 118, 869 (1963).

    Article  PubMed  CAS  Google Scholar 

  97. STARZL,T.E., MARCHIORO,T.L., HUTCHISON,D.E., PORTER,K.A., CERILLI,G.J., BRETTSCHNEIDER, L.: The clinical use of antilymphocyte globulin in renal homo- transplantation. Transplantation Suppl. 5, 1100 (1967).

    Google Scholar 

  98. STARZL,L, PORTER,K.A.: Antilymphocyte globulines, clinical use. In: Rappaport,F. T., Dausset, J. (Eds.): Human transplantation, p. 489. New York: Grund & Stratton 1968.

    Google Scholar 

  99. STEWART, P.B., BELL,R.: Procarbazine as an immunosuppressant in animals. J. Immunol. 105, 1271 (1970).

    PubMed  CAS  Google Scholar 

  100. STICH, W.: Medikamentöse Immunsuppression der immunopathologischen hämatolo- gischen Krankheiten. In: Ricken,D., Schmacher,K. (Hrsg.): Medikamentöse Immunosuppression, p. 143. Stuttgart: Georg Thieme 1971.

    Google Scholar 

  101. SWANSON,M.A., SCHWARTZ, R.S.: Immunosuppressive therapy. The relation between clinical response and immunological competence. New Engl. J. Med. 27, 163 (1967).

    Article  Google Scholar 

  102. SZOBAR,A., PETRANYI,G.: Immunosuppressive therapy of myasthenia gravis. Acta med. Acad. Sci. hung. 27, 397 (1970).

    Google Scholar 

  103. TALLENT,M.B., SIMMONS, R.L., NAJARIAN, J.S.: Birth defects in child of male recipient of kidney transplant. J. Amer. med. Ass. 211, 1854 (1970).

    Article  CAS  Google Scholar 

  104. TAO,T.W., Uhr,J.W.: Capacity of pepsin-digested antibody to inhibit antibody formation. Nature (Lond.) 212, 208 (1966).

    Article  CAS  Google Scholar 

  105. TRIPATHY, S. P., MACKANESS, G. B.: The affect of cytotoxic agents on the primary immune response to Listeria monocytogenes. J. exp. Med. 130, 1 (1969).

    Article  PubMed  CAS  Google Scholar 

  106. TURCOTTE, J. G., HAINES, R. F., BRODY, G. L., MEYER, T. J., SCHWARTZ, R. A.: Immuno-suppression with medroxyprogesterone acetate. Transplantation 6, 248 (1968).

    Article  PubMed  CAS  Google Scholar 

  107. UHR,J.W., Müller, G.: Regulatory effect of antibody on the immune response. Advanc. Immunology 8, 81 (1968).

    Article  CAS  Google Scholar 

  108. VARESE,L.A.: Terapia con immunosuppressari nelle sindromi nefrosiche primitive in eta pediatrica. Minerva pediat. 23, 282 (1971).

    Google Scholar 

  109. WANY,K.I., BARON, S., LEVY,H.B., WARD,T.G.: Actinomycin D: relative resistance of Green Monkey kidney cell cultures to its action. Proc. Soc. exp. Biol. (N.Y.) 125, 65 (1967).

    Google Scholar 

  110. WATSON,D.W., JOHNSON,A.G.: The clinical use of immunosuppressants. Med. Clin. N. Amer. 53, 1225 (1969).

    PubMed  Google Scholar 

  111. WEISBERGER,A.S., Wolfes: Effect of chloramphenicol protein synthesis. Fed. Proc. 23, 976 (1964).

    PubMed  CAS  Google Scholar 

  112. WHO Conference on use of antimetabolites in disease associated with abnormal immune responses. In: Miescher,P.A., Grabar,P. (Eds.): Proc. Vth Internat. Symposium Immunopathology, p. 359–418. Basel: Schwabe & Co. 1968.

    Google Scholar 

Download references

Authors
  1. P. A. Miescher
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. A. Gerebtzoff
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. P. H. Lambert
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

P. Frick G.-A. von Harnack G. A. Martini A. Prader R. Schoen H. P. Wolff

Rights and permissions

Reprints and permissions

Copyright information

© 1974 Springer-Verlag Berlin Heidelberg

About this paper

Cite this paper

Miescher, P.A., Gerebtzoff, A., Lambert, P.H. (1974). Immunosuppressive Therapie. In: Frick, P., von Harnack, GA., Martini, G.A., Prader, A., Schoen, R., Wolff, H.P. (eds) Ergebnisse der Inneren Medizin und Kinderheilkunde. Ergebnisse der Inneren Medizin und Kinderheilkunde. Neue Folge Advances in Internal Medicine and Pediatrics, vol 34. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-65746-7_1

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-65746-7_1

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-65748-1

  • Online ISBN: 978-3-642-65746-7

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation